Medtronic Announces FDA Approval of Minimally Invasive Device to Treat Hypertension
Approval is the culmination of 10 years of clinical research and development of the Medtronic renal denervation technology
Stay updated with breaking news from Hypertension Section. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Approval is the culmination of 10 years of clinical research and development of the Medtronic renal denervation technology
The Symplicity™ blood pressure procedure offers patients a new adjunct approach to lowering blood pressure Approval is the culmination of ten years of clinical research and development of the...
Adding blood pressure measurements while a patient is standing increases the sensitivity to detect hypertension, a new study suggests.
Self-measured blood pressure programs led by community health centers in the National Hypertensive Control Initiative led to significant improvement in control rates in at-risk populations.
Adults who experience hypertension while supine have a higher risk of adverse CVD events independently of their BP while seated, suggesting CVD may be missed if BP is measured only when seated upright.